UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000017075 |
|---|---|
| Receipt number | R000019806 |
| Scientific Title | the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug |
| Date of disclosure of the study information | 2015/04/13 |
| Last modified on | 2018/04/12 17:41:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug
Acronym
the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug
Scientific Title
the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug
Scientific Title:Acronym
the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug
Region
| Japan |
Condition
Condition
the patients whom schedulled to proposed operation or emergent operation
Classification by specialty
| Ophthalmology | Anesthesiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We would like to evaluate qualitative valiation of coagulation function and platelet function afeter having stopped to use anti-platelet drug or anti-coagulant drug in perioperative period
Basic objectives2
PK,PD
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the data to obtain by Sonoclot®, the correlation between the preoperative value of blood test and the postoperative that, and the validity of in-hospital standard for stopping to use anti-platelet or anti-coagulant drug
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Device,equipment |
Interventions/Control_1
Sonoclot which be able to measure coagulation function and platelet function
intervention period is one day
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | <= |
Age-upper limit
| 90 | years-old | > |
Gender
Male and Female
Key inclusion criteria
the patients from 15 to 89 years old, whom schedulled to proposed operation or emergent operation and stopped to use anti-platelet or anti-coagulant drug
Key exclusion criteria
examinee whom has no agreement or has declinature
examiee whom doctors confirmed to stop the administration of the study
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mitsutaka Edanaga |
Organization
Sapporo Medical University School of Medicine
Division name
Department of Anesthesiology
Zip code
Address
S1,W16 chu-oku, Sapporo, Hokkaido, Japan
TEL
011-611-2111
edanaka@sapmed.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuhiro Nakane |
Organization
Sapporo Medical University School of Medicine
Division name
Hospital Division
Zip code
Address
S1,W16 chu-oku, Sapporo, Hokkaido, Japan
TEL
011-611-2111
Homepage URL
akifujito@sapmed.ac.jp
Sponsor or person
Institute
Sapporo Medical University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Department of Anesthesiology, Sapporo Medical University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 04 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 12 | Month | 18 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 04 | Month | 13 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 04 | Month | 08 | Day |
Last modified on
| 2018 | Year | 04 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019806
